| Dimension | United States | United Kingdom |
|---|---|---|
| Official position on vaping for cessation | Cautious; FDA does not broadly recommend | Endorsed; NHS prescribes through stop-smoking services |
| Regulatory pathway | PMTA (premarket application, ~48 products authorized) | MHRA notification (no pre-approval required) |
| Flavor restrictions | State-level bans (CA, MA, NY, NJ); federal enforcement gap | Disposable ban since June 2025; refillable still allowed |
| Public health messaging | "Not safe, not FDA-approved" default | "At least 95% less harmful than smoking" (PHE) |
| Same Cochrane evidence, different policy | Regulatory caution despite evidence | Clinical implementation of evidence |
Loading…




